The evidence

What this does not do

The honest boundaries: what public data cannot tell you, which numbers are upper bounds, and where a human has to make the call.

Every analytical product has a boundary. Most of them are discovered by a customer, in a meeting, at the worst possible moment. Ours is written down here.

None of the limits below is a defect. They are the honest shape of what public evidence can support — and knowing them is what lets you use the parts that are strong.

It is not a prediction#

Probability of success is a base rate drawn from comparable programmes, presented as directional evidence with its assumptions visible. It is not calibrated to your programme and is not a forecast or a guarantee of your trial’s outcome.

The same applies to confidence scores: while uncalibrated they order results rather than measure them.

Some numbers are upper bounds#

Cohort figures are computed from epidemiology and eligibility modelling. They describe how many patients could in principle qualify — not how many you will enrol.

  • The eligible pool passes the modelled criteria and a screen-failure prior. No reach, catchment or consent stage is modelled, so it is an upper bound.
  • Prevalence snapshots are point estimates for sizing, not a live epidemiology feed.
  • Intervals around a modelled figure come from the modelling. Where the underlying epidemiology publishes no interval, the spread is an assumption and is labelled as one.

Budgets are bands, and wide ones#

Cost feasibility is built from public per-patient priors, presented as a low–median–high band rather than a quote. Treat public-data budgets as roughly ±50%. They are useful for comparing designs and countries; they are not a substitute for a CRO bid.

It only knows what is public#

  • Unregistered trials, unpublished results and confidential competitor programmes are invisible to it.
  • Registry data is only as accurate and as current as the sponsor who filed it.
  • Sparse indications produce sparse assessments — which the evidence bands and the evidence ledger will show you plainly rather than papering over.

A human makes the call#

The platform produces decision-support material. It is not a medical device, it does not practise medicine, and it does not approve anything. Deliverables are drafts until a named person on your team reviews and signs them.

Decision-support only — not a medical device.

See a verdict you can actually check.

Send us a protocol — or just a molecule and an indication. We'll return a fully cited feasibility assessment you can trace, line by line, back to public data — yours to defend in a bid, take to your board or investment committee, or hand to a regulator.